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SUMMARY 
 
The purpose of this study was to assess clinical and patient-reported outcomes following living 
kidney donor nephrectomy, with particular emphasis on patient-reported outcomes. A combination 
of quantitative and qualitative research methodology was used.  In a randomized, controlled trial of 
122 donors we compared laparoscopic and open donor nephrectomy, focusing on donor safety and 
per - and postoperative complications (Paper I), postoperative pain and convalescence (Paper I and 
II), and health status and overall quality of life at 1, 6 and 12 months follow-up (Paper III). The 
results demonstrated that the conventional open donor nephrectomy is superior to laparoscopic 
donor nephrectomy with regard to donor safety. Yet, an uncomplicated laparoscopic donor 
nephrectomy has important short-term advantages such as less analgesic requirements, less 
postoperative pain, better health status and a shorter sick leave as compared to the open approach. 
However, long-term follow-up only revealed significant differences in favour of laparoscopy when 
adjusting for reoperations and conversions. We therefore conclude that long-term benefits are hard 
to prove in favour of the laparoscopic technique. To explore the donors’ narrative experiences of 
going through donor nephrectomy, we in-depth interviewed 12 donors at one week (Paper IV) and 
at one year (Paper V) after donation. A positive feeling about being a donor was the dominant 
theme in both interview series. Though experiencing disincentives from surgery during the first 
postoperative period, the donors expressed that they were back to normal health condition a year 
after surgery, also confirmed by our quantitative investigation. Donors experiencing unsuccessful 
recipient outcome did not regret donation. On the contrary they remained confident in themselves, 
thinking they did what they could do to help a close family member.  
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INTRODUCTION 
 
Kidney transplantation is the optimal treatment for patients with end stage renal disease (1). There 
are two sources of kidneys for transplantation, deceased donors and living donors. Several studies 
show that kidneys from living donors provide superior immediate and long-term function, do not 
require prolonged waiting times, and are more cost - effective than those from deceased donors (2-
4). However, the use of living donors for kidney transplantation not only affects patients with end 
stage renal failure, but also the healthy persons who volunteer to donate. The main objection to 
living kidney donation is that it exposes the healthy donor to the risks of major surgery and a life 
with just one kidney (5, 6). The available evidence, mainly from retrospective surveys, suggests that 
donor nephrectomy is generally very safe, with a perioperative mortality of about 0, 03 % (7). 
Postoperative problems associated with kidney donations are pain related to the wound and 
temporary occupational disability (8 -10). Careful, prospective follow-ups of large numbers of 
living donors have been uncommon, so the knowledge of the situation of going through living 
donor nephrectomy has been incomplete (11, 12), and in particular as seen from the donors’ 
perspective. In Norway almost 40 % of all renal transplants are performed with organs from living 
donors (13) and efforts are made to increase the share of living kidney donors to increase the 
number of kidneys available for transplantation. At Rikshospitalet HF open donor nephrectomy has 
been the established treatment for living kidney donors. However, since 1998 laparoscopic donor 
nephrectomy has been experimentally performed at our hospital. In their report from 2000, Merlin 
et al concluded that the evidence-base for open and laparoscopic living donor nephrectomy has been 
inadequate to make recommendations regarding which technique is the best (11). The donors 
undergo the operation for altruistic reasons and the techniques are performed on healthy individuals. 
Hence, it is important to increase the knowledge base in this area. On this background we 
performed a broad evaluation project at our centre, including objective, subjective and economic 
donor outcomes. The present work investigates clinical and patient-reported outcomes following 
laparoscopic and open donor nephrectomy, with particular emphasis on patient-reported outcomes. 
The use of patient preferences to evaluate medicine and health care interventions is becoming more 
accepted in the medical community, and in particular with regard to clinical trials (14). The term 
patient-reported outcomes has now become accepted as important because it indicates interests in a 
number of outcomes and provides the patient’s perspective on the treatment (15-18). Such outcomes 
can therefore be used both for comparative purposes in the evaluation of different treatments, and 
for descriptive purposes. Profiles of patient-reported data provide a source of information about the 
possible consequences of therapy, and this information can be shared with patients when deciding 
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which treatment may be the most suitable. To investigate clinical and patient-reported outcomes 
following living donor nephrectomy we applied a combination of a quantitative and a qualitative 
research approaches to shed light on different aspects regarding living donor nephrectomy 
 
LIVING KIDNEY DONATION 
 
The first successful living donor nephrectomy was performed in 1954 in Boston, USA (19). Since 
then, the number of living kidney donations has increased worldwide. In Norway kidney 
transplantation was established as a routine procedure in Norway in 1969 (20). Figure 1 
demonstrates donor sources in Norway in the period 1969-2007.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Kidney transplantations in Norway by donor source, dark grey bars indicate proportions 
of kidneys from deceased donors and grey bars indicate proportions of kidneys from living donors 
(figure adapted from Bakkan, 2008).    
 
Advantages of living donor kidney transplantation 
Living donor renal transplantation is superior to deceased renal transplantation in regard to graft and 
patient survival. Although the gap in graft survival between living related and deceased renal 
transplantation has narrowed considerably, living related donor grafts still have about 10 % better 
survival rate at 1 year and a significantly higher probability of function thereafter (21). There are 
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several reasons for this. First, living kidney donors have been fully screened and provide kidneys 
with a guaranteed high quality. Second, living kidney donation allows for transplant surgery to be 
scheduled to ensure optimal physical and emotional health of both the donor and the recipient. 
Third, these transplants are often pre-emptive, occurring before dialysis is necessary and allowing 
recipients to avoid waiting lists. Other important factors are that organs from deceased donors 
include the patho-physiological changes associated with brain death of the donor, maintenance in 
the intensive care unit and possibly extended cold ischemia times (22). 
 
The donation procedure 
Donor nephrectomy can be performed by either open or laparoscopic surgery and there are several 
techniques for both types. Open nephrectomy is performed by conventional retroperitoneal access 
through a flank incision at the level of costa 11 to 12, most often without rib resection. The donor is 
placed in an extended flank position (23). Laparoscopic nephrectomy is performed by a trans-
peritoneal approach with the patient positioned in flank position with angulation. Six ports are used 
and the video-laparoscope is introduced through an infraumbilical port (24). The hand-assisted 
variation of the laparoscopic nephrectomy was developed to give surgeons greater tactile feedback 
and to facilitate the definition of tissue planes. It has been suggested that this may reduce the 
operating room time and allow transplant centres that lack advanced laparoscopic expertise to 
perform the donor surgery safely (25, 26). A few randomized (27, 28) and several non-randomized 
(29-35) studies have been performed to compare laparoscopic versus open living donor 
nephrectomy. In short, results suggest that the procedures are comparable regarding graft function. 
Further, as the open approach seems to be a very safe procedure, the laparoscopic approach is 
associated with a briefer convalescence and a better or equal quality of life as compared to the open 
approach.  
 
Short and long-term risk following living kidney donation  
Donor nephrectomy is associated with low morbidity and low mortality (36-42). Total morbidity, 
including minor complications, has been calculated to be roughly 10 percent (43, 44). Problems 
associated with kidney donations are postoperative pain and temporary occupational disability (45-
49). Long term issues include the possibility of chronic pain, the risk of a slight rise in blood 
pressure and the increased incidence of proteinuria. Most series document about 5 % of the donor 
population with chronic pain or other problems directly related to nephrectomy (50). Yet, there is 
evidence that most donors recover well from the surgery and are back in normal health condition 
after donation (51-54). The psychosocial impact of donor nephrectomy has also been evaluated. 
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This includes a benefit in self-esteem and increased self-worth, and a strong donor-recipient 
relationship (55-58), but also a risk of sequel after the donation such as experience of stress and 
mild depression (59-65), and reaction to transplant failure or death of the recipient (66-67).  Worries 
about medical costs and loss of income related to the donation process have also been documented 
(49). 
 
Ethical and legal issues of living kidney donation 
Living kidney donation raises many ethical issues. The key issue is whether the removal of a 
healthy kidney from a person constitutes harm. On the other hand, should not the autonomy of the 
donor who wishes to improve the quality of life of a closely linked individual be respected? Each 
case must be evaluated carefully to ensure minimum risk to the donor and maximum benefit to the 
recipient. Living donations historically have all been directed between family members and friends, 
are considered ethically acceptable (68-70), and are performed according to policies established at 
individual transplantation centres (71). In view of the potential risk to a living donor, it is generally 
accepted that all things being equal it is preferable to use deceased rather than a living organ donor. 
Moreover, other options are usually available to sustain life following end-stage renal failure. 
Article 19 of the Council of Europe Convention on Biomedicine stipulates that “living organ 
donation is only permissible where there is no suitable deceased organ available and no other 
alternative therapeutic method of comparable effectiveness” (72). Persons who donate a kidney 
should be competent, willing to donate, and free from coercion from other persons (73). Informed 
consent is required for major surgery and Appelbaum and Grisso describe four important principles 
for being competent to give a valid consent: i) the ability to communicate choices, ii) to understand 
relevant information about a treatment decision, iii) to understand the situation and the specific 
implications that it carries for one’s future, and iv) to handle information rationally (74).  
 
PATIENT-REPORTED OUTCOMES    
 
The main focus in the present thesis is the evaluation of patient-reported outcomes following living 
kidney donation.  The term patient-reported outcome addresses the source of the report rather than 
the content (18). It thus can be seen as an umbrella term to describe a broad spectrum of disease and 
treatment outcomes reported subjectively by the patient, such as health status measures, symptoms 
report and patient satisfaction with treatment (75, 76). Today patient-reported outcomes have 
evolved to include any endpoint derived from patient reports, both from the evaluation and 
comparison of treatments and for the assessment and management of individual patients. 
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Knowledge of patient experiences when treatment options are implemented serves to guide health 
personal so that interventions are timed, adjusted, and can contribute to the maximal benefit from 
surgery. A key challenge remains our ability to link patient-reported outcomes with clinical 
endpoints when new treatments are evaluated. The present work addresses this challenge by 
investigating patient-reported outcomes in a broad evaluation where objective and subjective 
assessments are investigated in patients going through living donor nephrectomy. Patient-reported 
outcomes were conceptualized as overall quality of life, health status, and disincentives related to 
surgery such as pain and the surgical scar. Also narrative donor experiences derived through in-
depth interviews were part of patient-reported outcomes investigated in this thesis. The latter was 
integrated to get a more complete picture of the donors’ situation. Phenomenological descriptions 
can provide health personal with different perspectives on a phenomenon as the focus is on 
individual experiences and how the persons express meaning about some aspects of their lives (77-
79).  
 
The concept of quality of life – origin and expansion 
Of the most central concepts that fall within the term patient-reported outcomes are quality of life. 
This is a relatively new concept emerging from the political discussions in North America in the 
1960s and has been widely debated during the last decades. The concept is used in a multitude of 
settings, and different professional groups attach different meanings to the concept. In medicine, the 
concept quality of life has gained more and more attention during the past 20-30 years as linking 
patient-reported health with clinical endpoints provides unique information for managing patient 
care (80). As quality of life-measurements allow for mapping of the impact of disease they have 
been used both for the evaluation and comparison of treatments and for the assessment and 
management of individual patients (81). Also, they complement traditional endpoints to evaluate the 
significance of a treatment effect from the patient’s perspective; and thus can facilitate patient’s 
involvement in treatment decision making. A universally accepted definition of quality of life has 
not been developed. Nevertheless, the majority of the researchers have agreed that quality of life is 
a subjective and multi-dimensional concept including dimension such as physical, psychological, 
social and spiritual dimensions (82-85). 
 
An important recommendation for quality of life-research is to base studies on a conceptual model 
of quality of life that incorporates the multidimensionality of the concept and strengthens the link 
between theory and research (86). In the present thesis, we distinguished between different levels of 
quality of life, according to a model (Figure 2) developed by Spilker (87). 
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Figure 2.  A model combining measurement of the overall, generic and disease related aspects of 
quality of life (Spilker, 1996).  
 
 
Following this model, the quality of life definitions and measures can be grouped on three levels: i) 
the individual’s overall satisfaction with life, ii) a generic level such as the individual’s satisfaction 
with different life domains (physical, psychosocial and spiritual), and iii) disease specific symptoms 
or disability (87). Both the overall and generic level includes general domains, which are applicable 
to well and ill populations. The specific level focuses on the individual’s perception of disease-
related factors, such as disability caused by a specific disease. Dependent on the perspective, one 
level could impact on the other. Concepts such as disability, well-being, health and symptoms have 
been used interchangeable with the concept of quality of life. The relationship between these 
concepts is complex. It is quite clear that the concepts are related to each other. However, they are 
not the same (88, 89). In the present study the overall level is represented by The Quality of Life 
Scale-Norwegian (85, 90), the generic level is represented by the Short Form-36 (91) whereas 
several disincentives related to donor surgery, such as postoperative pain measured by the Visual 
Analogue Scale (92), represent the specific level. 
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Definitions  
The following definitions of concepts are used in the present study: 
 
• Overall quality of life is defined as a person’s wellbeing that stems from satisfaction or 
dissatisfaction with areas that are important to him or her (93).  
 
• Health is, by the WHO, defined to be ‘a state of complete physical, mental, and social well-
being, and not merely the absence of disease’ (94). 
 
•  Health status. In this work the term health status includes the patients’ perception of 
functioning, disability and well-being related to physical, mental and social health 
dimensions. These dimensions consist of eight concepts: physical functioning, role physical, 
bodily pain, general health perceptions, vitality, social functioning, role-emotional, and 
mental health (95). 
 
• Pain is, by the International Association for the Study of Pain (IASP), defined as “an 
unpleasant sensory and emotional experience associated with actual or potential tissue 
damage, or described in terms of such damage” (96). 
 
AIMS OF THE STUDY  
 
The overall aim of the present thesis was to investigate clinical and patient-reported outcomes 
following living donor nephrectomy, with particular emphasis on patient-reported outcomes. The 
objectives of the various papers comprising this study were: 
 
• To assess the effect of laparoscopic versus open living donor nephrectomy on (1) operative 
time, warm ischemia time, length of renal artery and vein; (2) peri - and postoperative 
complications; and (3) the amount of analgesic administered and postoperative pain 
intensity as measured by a categorical verbal rating scale (VRS) at postoperative days 0 + 
1(Paper I).  
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• To assess the effect of laparoscopic versus open living donor nephrectomy on (1) the 
amount of analgesic administered at postoperative days 0, 1 and 2; and (2) postoperative 
pain intensity as measured by a visual analogue scale (VAS) at postoperative day 2 (Paper 
II). 
 
• To assess the effect of laparoscopic versus open living donor nephrectomy at 1 month 
postoperative on (1) numbers of donors reporting surgery related pain; (2) surgery related 
pain intensity as measured by a numeric rating scale (NRS); (3) use of pain medication 
during the last 24 hours, and during the last week; and (4) duration of sick leave (Paper II). 
 
• To assess the effect of laparoscopic versus open living donor nephrectomy at 1, 6 and 12 
months after donor surgery on (1) overall quality of life as measured by the Quality of Life 
Scale-Norwegian (QOLS-N); and (2) health status as measured by The Short Form-36 (SF-
36) (Paper III). 
 
• To assess the effect of laparoscopic versus open living donor nephrectomy on (1) the 
patients’ perception of the surgical scar; (2) the donation’s impact on personal finances; and 
(3) whether the patients would make the same decision to donate again (Paper III). 
 
• To explore physical and psychosocial issues related to the patients’ experiences of going 
through open donor nephrectomy at one week after surgery (Paper IV).  
   
• To explore the patients’ experiences of their physical and psychosocial health during the 
first year following open donor nephrectomy (Paper V).    
   
RESEARCH QUESTIONS AND 0-HYPOTHESES 
 
In the following the specific research questions and 0-hypotheses raised in this study are presented. 
 
Paper I. 
1. Is there a difference in the effect of laparoscopic versus open living donor nephrectomy on (1) 
operative time, warm ischemia time, length of renal artery and vein; and (2) complication rate and 
reoperations in the peri - and postoperative period?  
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0-hypothesis: There is no difference in the effect of laparoscopic versus open living donor 
nephrectomy on (1) operative time, warm ischemia time, and length of renal artery and vein; (2) 
complication rate and reoperations in the peri - and postoperative period.  
  
2. Is there a difference in the effect of laparoscopic versus open living donor nephrectomy at 
postoperative days 0 + 1 on (1) the amount of parenteral morphine equivalents administered; and 
(2) pain intensity as measured by a categorical verbal rating scale (VRS), at rest and in motion?   
0-hypothesis: There are no differences between groups at postoperative days 0 + 1 on (1) the 
amount of parenteral morphine equivalents administered; and (2) pain intensity as measured by a 
categorical verbal rating scale (VRS), at rest and in motion.   
 
Paper II  
3. Is there a difference in the effect of laparoscopic versus open living donor nephrectomy on (1) the 
amount of parenteral morphine equivalents administered at postoperative days 0, 1 and 2; and (2) 
pain intensity as measured by a visual analogue scale (VAS) at postoperative day 2, at rest and in 
motion? 
0-hypothesis: There are no differences between groups on (1) the amount of parenteral morphine 
equivalents administered at postoperative days 0, 1 and 2 and; (2) pain intensity as measured by a 
visual analogue scale (VAS) at postoperative day 2, at rest and in motion. 
 
4. Is there a difference in the effect of laparoscopic versus open living donor nephrectomy on 
surgery related pain at 1 month post donation on (1) numbers of donors reporting pain; (2) pain 
intensity as measured by a numeric rating scale (NRS) ; and (3) use of pain medication during the 
last 24 hours, and during the last week? 
0-hypothesis: There are no differences between groups on surgery related pain at 1 month post 
donation on (1) numbers of donors reporting pain; (2) pain intensity as measured by a numeric 
rating scale (NRS); and (3) use of pain medication during the last 24 hours, and during the last 
week. 
 
5. Is there a difference in the effect of laparoscopic versus open living donor nephrectomy on 
duration of sick leave? 
0-hypothesis: There is no difference between groups on duration of sick leave. 
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Paper III 
6. Is there a difference in the effect of laparoscopic versus open living donor nephrectomy on (1) 
overall quality of life as measured by the Quality of Life Scale-Norwegian (QOLS-N); and (2) 
health status as measured by The Short Form-36 (SF-36) at 1, 6 and 12 months after donor surgery? 
0-hypothesis: There are no differences between groups on (1) overall quality of life as measured by 
the Quality of Life Scale-Norwegian (QOLS-N); and (2) health status as measured by The Short 
Form-36 (SF-36)  at 1, 6 and 12 months after donor surgery. 
 
7. Is there a difference in the effect of laparoscopic versus open living donor nephrectomy on (1) the 
patients’ perception of the surgical scar; (2) the donation’s impact on personal finances; and (3) 
whether the patients would make the same decision to donate again? 
0-hypothesis: There are no differences between groups on (1) the patients’ perception of the 
surgical scar; (2) the donation’s impact on personal finances; and (3) whether the patients would 
make the same decision to donate again. 
 
Paper IV 
8. What are the patients’ narrative experiences related to physical and psychosocial issues of going 
through open donor nephrectomy at one week after surgery? 
 
Paper V 
9. What are the patients’ narrative experiences of their physical and psychosocial health during the 
first year following open donor nephrectomy?  
 
METHODS 
 
This thesis is based on three quantitative studies (Paper I-III) and two qualitative studies (paper IV 
and V). 
 
Quantitative studies (Paper I-III) 
Design 
A prospective, randomized single centre trial was performed to compare clinical and patient- 
reported outcomes after laparoscopic versus open donor nephrectomy. 
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Pilotstudy 
A pilot study was conducted prior to the main study with the purpose to assess a common 
standardized anaesthesia - and analgesia regime for both groups. A sample of 10 living donors 
participated. The patients were given medication according to the study regime and were asked to 
assess pain and symptoms postoperatively. The new regime demonstrated satisfactory anaesthetic 
and pain-release, and was established for all study patients.  
 
Randomization  
Information to nephrologists at local hospitals in Norway  
Information letters including information about study aims and methods, were sent to all 
nephrologists at local hospitals before study start (in July 2000), and then a reminder at the start of 
the inclusion period in February 2001. In addition, information meetings were held with 
nephrologists at local hospitals in Norway, and surgeons and nephrologists at Rikshospitalet HF 
before and during study period.  
 
Information to donors and inclusion  
During initial evaluation for donation, nephrologists at local hospitals in Norway informed potential 
donors about the study, both verbally and in written text. Further, more extensive information was 
given to the donors at Rikshospitalet HF after admission, by the surgeons at the Department of 
Surgery. The inclusion was performed 1 - 4 days prior to donor surgery by the surgeons at the 
Department of Surgery. 
 
Randomization procedure  
To assure that the allocation of the treatment was carried out in an unbiased and random way, 
donors who fulfilled the inclusion criteria and had signed the informed consent form, were 
randomized to either laparoscopic or open donor nephrectomy. Well-established procedures were 
followed for the randomization process (97, 98). Due to a long inclusion period (from February 
2001 to May 2004) the donors were randomized in blocks of 20. During the entire study period two 
persons, one researcher employed at the Department of Surgery, the other employed outside the 
department, randomly drew letters labelled either laparoscopic (10) or open technique (10), in 
blocks of 10 + 10. The letters were randomly mixed and blindly put into opaque envelopes pre-
labelled with inclusion numbers of all participants. After having signed the informed consent form 
at Rikshospitalet HF, the donors were included by the surgeon and were allocated the next, 
sequentially pre-numbered randomization envelope. 
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Population and sample 
The inclusion criteria were as follows: age 18 and older, and fulfilling existing criteria for donation 
with a single, left renal artery. The donors were not included if i) they had a history of extensive 
upper abdominal surgery, ii) there were findings suggesting right nephrectomy, and iii) they were 
not able to understand and speak Norwegian. There was no further selection. A total number of 240 
living donor nephrectomies were performed during the inclusion period. Among the 118 donor 
nephrectomies not included in the study, there were two laparoscopic nephrectomies and 116 open 
nephrectomies. The reasons for performing open donor nephrectomy in 116 cases were: 
administrative circumstances (the two laparoscopic surgeons were not available), right kidney 
retrieval (due to multiple renal arteries on left side, incompatible kidney size) and extensive 
previous abdominal surgery. Obesity was not considered a contraindication. Less than five eligible 
donors were rejected for other reasons. A total of 122 living kidney donors were randomized to 
laparoscopic or open donor surgery. The laparoscopic and the open group were comparable with 
regard to age, sex, BMI and donor-recipient relationship. Mean age in the laparoscopic group was 
46 years versus 45 years in the open group. The laparoscopic group consisted of 29 males and 34 
females, whereas there were 26 males and 33 females in the open group. The attitude of the 
Norwegian population regarding laparoscopic versus open surgery was quite balanced during the 
study period, and the donors were informed that there was no hard evidence in favour of either 
procedure. Before surgery only one patient opted out and was excluded from the study as a 
consequence of being randomized to open donor nephrectomy. During follow-up there were five 
drop outs in the laparoscopic group, respective 3 in the open group. Reasons for drop outs in the 
laparoscopic group were: problems with reading and writing Norwegian (1), illness of a family 
member in the donor’s family (1), not willing to participate in the study from the 6 months follow-
up (1), and unknown reasons (2). Reasons for drop outs in the open group were: donors moving to 
another place (2), and unknown reasons (1). All reoperated and converted donors responded at all 
follow-ups and consequently were not among the drop outs of the study (Figure 3).  
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Figure 3. Flow of donors through the trial. 
 
Surgical techniques 
All laparoscopic donor nephrectomies were performed in the flank position, with 
pneumoperitoneum at 9-11 mm Hg, trans-peritoneal access through 4-5 ports, and dissection mainly 
by means of a 5-mm ultrasonic knife. The first 17 laparoscopic donor nephrectomies were 
completed by conventional technique, using a basket for kidney extraction through a midline 
infraumbilical incision. The last 46 laparoscopic donor nephrectomies were completed by 
employing a modified, simple hand-assisted technique (99). During the final stages, the left hand 
240 donations 
performed in the 
inclusion period 
118 donors not included 
 - laproascopic surgery (2) 
 -  open surgery (116) 
 
Reasons for open surgery 
- 1 opted out as a result of 
   randomization 
- administrative reasons 
- right kidney retrieval 
- extensive previous surgery 
- other reasons 
           122 randomized 
63 laparoscopy    59 open 
63 at 1 month 
follow-up 
57 at 1 month 
follow-up 
56 at 6 months 
follow-up 
58 at 12months 
follow-up 
56 at 12 months 
follow-up 
61 at 6 months 
follow-up 
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was introduced through a minimal incision (infraumbilical; without handport), to facilitate the 
handling and evacuation of the free kidney. Only a long left glove was needed for this modification. 
The required incision was of the same length as needed for basket extraction (6-9 cm). The open 
donor nephrectomies were performed by conventional retroperitoneal access through flank incision 
at the level of costa 11 to 12, and without rib resection. The length of the skin incision varied from 
12 to 18 cm. Two different surgeons randomly performed the pure laparoscopic nephrectomies, one 
with extensive and one with moderate laparoscopic experience. After the shift to the hand-assisted 
technique, the surgeon with moderate laparoscopic experience was responsible for the laparoscopic 
procedures. Six different surgeons, all experienced transplant surgeons, randomly performed the 
open donor nephrectomies.  
 
Peri - and postoperative analgesia regimen 
All donors received anaesthesia and postoperative analgesia guided by the same protocol (100). At the 
start of the donor operation 8 mg dexamethason was administered intravenously as a single dose, while 
intravenous pro-paracetemol and ketorolac were started at the end of anesthesia. On the day of surgery 
and on postoperative day 1 and 2 the donors received pro-paracetamol 2 g x 4 and ketoralac 30 mg x 3 
intravenously; thereafter oral medication; paracetamol 1 g x 4 and ketoralac 10 mg x 4. For the first 
postoperative days, a patient controlled analgesic pump (PCA) delivered intravenous opioid pain relief 
(ketobemidon) in bolus doses of 0, 1 mg/kg body weight, each dose trigged by the patient.  PCA was 
discontinued between postoperative days 2-5, whereafter oral ketorolac was offered.  
 
Data collection  
Clinical data were collected through medical charts in the peri- and postoperative period. Patient- 
reported data were collected through bed-side interviews at postoperative day 0-2, and by 
questionnaires. Questionnaires were completed on admission 1-2 days prior to surgery (baseline), 
and were responded to by mail at 1, 6 and 12 months post donation. Figure 4 demonstrates strategy 
of data – collection.  
 
Base-       Surgery       Postoperative              1 month                                 6 months                                     12 months 
line                                 days 0-2 
________________________________________________________________________________ 
T0                 X                   T1                               T2                                           T3                                                 T4 
________________________________________________________________________________________________ 
 
Figure 4. Strategy of data collection.  X = donor surgery, T0 - T4 = data collection. 
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Clinical data 
Donor safety and peri - and postoperative complications  
To obtain data on donor safety and peri - and postoperative complications we collected data of 
operative time, warm ischemia time, length of renal artery and vein, perioperative incidents, 
reoperations, and conversions. We defined operative time as time elapsed from skin incision to 
placement of the final skin suture, and warm ischemia time as time elapsed from clamping of the 
renal artery to initiation of cold perfusion. Length of renal artery and vein was measured to the edge 
of the parenchyma in the hilus, without stretching. Data were obtained from medical charts. 
 
The amount of ketobemidon administered at postoperative days 0-2 
The amount of ketobemidon administered on postoperative 0-2 was obtained from medical charts 
and was reported as units of parenteral morphine equivalents (mg).  
 
Patient- reported data 
The Quality of Life Scale-Norwegian (QOLS-N). The QOLS-N is a 16 - item, domain specific 
instrument containing dimensions of physical and material well-being, personal development, 
relationship with others, social and civic activities, recreation, and independence (85). The scale 
measures overall quality of life and was chosen because it has been shown to provide broad 
information of overall quality of life. Also, it has been validated for use in Norwegian psoriasis 
patients (85). The QOLS-N has access to previous psychometric testing (101,102). Internal 
consistency by Cronbach,s alpha is reported at 0.8 (85). The instrument was developed empirically 
in the US by asking healthy people about their quality of life. In 1998 it was adapted by Burckhardt 
et al, and adapted for use in patients with chronic diseases. The QOLS-N yields a single sum score, 
range 16 to 112, with higher scores indicating better quality of life.   
 
The Short Form – 36 (SF – 36). This instrument was chosen because it has been shown to be a 
valid, reliable and responsive questionnaire for assessing health status in both patients and healthy 
individuals (91). Internal consistency has been reported at 0.7 to 0.9 (91). Also the SF-36 has been 
found to be both sensitive and responsive when used to compare open and laparoscopic living donor 
nephrectomy (27, 28). The SF-36, which is based on the WHO definition of health, was developed 
in the US by the Medical Outcomes Study. The instrument is referred to as a generic measure 
because it assesses health concepts that represent basic human values that are relevant to everyone’s 
functional status and well-being. It has been extensively used since the 1990s and remains one of 
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the most well-documented surveys currently utilised in the area of health status and quality of life-
research. Respondents consider questions concerning health domains with regards to the four past 
weeks. The instrument has been translated to several languages, including Norway (103, 104).  The 
SF-36 consists of 36 questions regarding self-reported aspects of health and includes 8 domains: 
physical functioning, role limitations due to physical health problems, bodily pain, general health, 
vitality, social functioning, role limitation due to emotional problems, and mental health. The scores 
are transformed into a scale from 0-100. The higher the scores are, the better is the individual’s 
health.  
 
Postoperative pain.  
As pain is an individual and subjective experience influenced by several factors, a central question 
discussed in the project group before study start was how to measure pain in the clinical, 
randomized study. An important goal was that all participants should receive a common, satisfying 
postoperative pain relief regimen. At the other hand, one main study objective was to detect 
possible differences in postoperative pain intensity between groups. We therefore chose a strategy 
including two main outcomes reflecting postoperative pain: i) measurement of the amount opioid 
(ketobemidon) administered daily by a PCA pump, and ii) pain intensity. By doing so, we could be 
able to detect possible differences between the groups in the immediate postoperative period even if 
the donors’ pain intensity was reduced to a minimum level. Literature reviews performed before 
study start showed that amount of analgesics administered, and assessment of pain intensity, were 
common used endpoints in donor studies comparing lapaoscopic and open nephrectomy (8, 33, 
105). Thus, our strategy of pain measurement would allow comparison of the pain results from our 
study to previous research in this area.  
 
Measurement of pain intensity 
Literature search showed that pain intensity in general is most commonly evaluated either by 
categorical rating scales, visual analogue scales or numerical rating scales (106-108). We chose the 
categorical verbal rating scale (VRS) and the Visual Analogue Scale (VAS) for the measurement of 
pain intensity during postoperative days 0-2 to get valid and reliable data, and to have the 
opportunity to compare the results to previous research. Pain intensity at 1 month post donation was 
evaluated using a numeric rating scale (NRS), by questionnaire mailed to the donors one month 
after donation. All three scales are considered valid and reliable with regard to postoperative pain 
intensity (108 -110). 
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At the postoperative days 0 + 1 pain intensity was assessed by using the five point VRS at rest and 
in motion. Expert nurses asked the patients to rate their pain intensity using the following response 
alternatives: 0 = no pain, 1 = weak pain, 2 = moderate pain, 3 = strong pain, 4 = very severe pain. 
There were several reasons for using the VRS in the immediate recovery period. First, before and 
during study period the VRS had been a standard regime in our department regarding postoperative 
pain assessment in patients who were delivered patient-controlled analgesia. Thus, the VRS was a 
established instrument, and well known by the health care personnell, including the expert nurses 
who collected these data.  Second, previous studies have shown that this scale has satisfying 
psychometric properties (108, 109). Third, it is simple and quick to administer. It has been 
demonstrated that both patients and physicians are confident by using it (111, 112), thus the scale is 
commonly used.   
 
At the postoperative day 2 when the donors usually ambulate to pain-triggering out-bed activities 
pain intensity was measured by the VAS (92). Two trained researchers performed the standardized 
bed-side interviews by using the 10-cm horizontal VAS-scale to measure pain intensity at rest and 
during a standardised cough - and deep breath exercise. Patients were asked to draw a vertical line 
through the scale at a point representing the level of pain intensity, anchored on the left with words 
signifying no pain (= 0), and on the right side with words signifying the worst imaginable pain (= 
10). The VAS scale was chosen because this scale has in general become a standard with regard to 
pain assessment, the instrument has previously been validated (112), and has demonstrated 
important properties such as sensitivity, simplicity and reproducibility (108, 113). Also, it has been 
applied for the comparison of pain outcome following laparoscopic and open donor nephrectomy 
(105).  
 
At 1 month post donation a central question was how many donors in the laparoscopic versus the 
open group who suffered from surgery related pain. In the 1 month questionnaire sent by mail, the 
donors were asked whether or not they had experienced surgery related pain the last 24 hours. 
Those answering “yes” were asked to indicate their pain intensity by using a 11-pointed numeric 
rating scale (NRS), with marks printed on the line with 0 signifying no pain and 10 the worst 
imaginable pain. A numerical rating format was chosen because this allows the patients to rate their 
pain a simple and precise way by their own at home (the VAS can be more difficult to use for self 
administration and without an assessor available). It moreover allows a more differentiated 
assessment and a finer gradation of pain as compared to the VRS. When it comes to psychometric 
properties Breivik et al (108) has demonstrated similar sensitivity of the NRS and the VAS with 
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regard to postoperative pain assessment. The patients were also asked in the 1 month questionnaire 
whether or not they had taken any oral analgesic drugs related to donor surgery during the last 24 
hours, and during the last week.  
 
Donor specific questions 
At the 12 months assessment the donors were asked questions regarding their perception of the 
surgical scar, the donation’s impact on personal finances, and whether the donors would make the 
same decision to donate again.  To measure the donors’ perception of the surgical scar we used a 10 
cm horizontal Visual Analog Scale (92). Patients were asked to draw a vertical line through a scale 
anchored on the left-hand side with words signifying a very negative perception, and a very positive 
perception on the right-hand side. At 1, 6 and 12 months after donation the donors were asked to 
report on the occurrence of significant life events by answering the Life Events Index (114) and 
hereby were able to report on recipient death or graft failure. Finally, the donors were asked to 
report on their perception of the recipient’s health. 
 
Duration of sick leave 
Duration of sick leave was calculated as numbers of weeks after discharge from hospital being off 
sick. Data on donor employment were collected at baseline. The donors were categorized as 
employed, students, or unemployed (out of work, housewives, or retired persons). Donors being 
employed and donors being students were included in the sick leave inquiry. Data from 93 donors 
(51 in the laparoscopic group, 42 in the open group) were collected by structured telephone 
interviews at about one year after donation. The donors were informed that the aim of the telephone 
interview was to gain knowledge about the duration of sick leave following donor nephrectomy. 
Following question was asked: “For how many weeks after hospital discharge were you on sick 
leave?”  We registered the number of weeks of sick leave, and not number of days, because we 
considered it would be easier for the donors to give an exact answer to number of weeks away from 
work, compared to numbers of days. Besides, previous research on laparoscopic versus open 
technique has shown that weeks of sick leave following donor nephrectomy is a common used 
endpoint (33, 45).  
 
The table below summarizes variables and instruments, numbers of items, response scales, time of 
data collection, and reliability estimates for main instruments measuring patient-reported outcomes 
in the present study. 
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Time of data 
collection 
Variables and  
instruments 
 
Items 
 
Response scales 
 
T0 T1 T2 T3 T4 
Cron- 
bach’s  
alpha 
Overall quality of life  
QOLS-N; The Quality of 
Life Scale-Norwegian; 5 
domains: physical and 
material well-being, per-
sonal development, 
relationship with others, 
participation in social, 
community and civic 
activities, and recreation 
(85). 
 
16 
 
Likert scale ranging 
from 1 (very 
dissatisfied) - 7 (very 
satisfied). 
 
x 
  
x 
 
x 
 
x 
 
0,90 
Health status  
SF-36; 8 domains:   
physical functioning, 
role 
physical, bodily pain, 
general health, vitality, 
social functioning, role 
emotional, mental health 
(91). 
36 Different response 
scales: ordinal level 
and Likert response 
scales. Raw scores 
are trans-formed to 1 
- 100. Higher scores 
indicate better health. 
x  x x x 0,67- 
0,94 
Postoperative pain  
Postoperative days 0-2 
VRS; verbal rating scale 
(106), at rest and in motion. 
VAS, visual analogue 
scale (92), at rest and in 
motion.  
 
 
 
 
At 1 month post donation 
Surgical related pain:  
NRS; numeric rating 
scale (108). 
 
 
 
Use of analgesic drugs the 
last 24 hours/the last week. 
 
 
2 
 
2 
 
 
 
 
 
 
 
 
1 
1 
 
 
 
2 
 
 
Categorical scale (0 - 4). 
 
A 10 cm line 
anchored on the left 
with words signi-
fying no pain, on the 
right side words 
signifying the worst 
imaginable pain. 
 
 
Yes/no. 
Numeric rating scale 
(0 indicating no 
pain,10 indicating 
the worst pain). 
Yes/no. 
 
 
 
 
 
 
 
x 
 
x 
 
 
 
 
 
 
 
 
 
 
 
 
 
x 
x 
 
 
 
x 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Donor specific questions 
Donor - perception of the 
surgical scar, the donation’s 
impact on personal 
finances, decision to donate 
again, and donor - 
perception of  recipient 
health. 
Life Events Index (114). 
 
4 
 
 
 
 
 
 
8 
 
Different response 
scales: 5 - point Likert 
scale, visual analogue 
scale, Yes/no. 
 
 
  
 
 
 
 
 
 
x 
 
 
 
 
 
 
 
x 
 
x 
 
 
 
 
 
x 
 
Duration of sick leave. 
 
1 Numbers of weeks of 
sick leave. 
Telephone interview at about 1 year post 
donation. 
 
Table 1. Details of instruments measuring patient-reported outcomes. 
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Several variables were part of the randomized controlled trial. Table 2 provides a total overview of 
independent, dependent and confounding variables with regard to Paper I, II and III: 
 
Variables 
 
 Paper  I   Paper  II  Paper III 
Independent 
variable 
Laparoscopic versus open  
donor nephrectomy. 
 
x 
 
x 
 
x 
 
Dependent 
variables 
 
Operative time. 
Warm ischemia time. 
Length of renal artery and vein. 
Perioperative incidents/reoperations/conversions. 
Postoperative pain: 
- amount of analgesic administrated 
- pain intensity at rest and in motion 
Surgery related pain at 1 month post donation:  
- experience of pain? Yes/no 
- pain intensity 
- pain medication the last 24 hours? Yes/no 
- pain medication the last week? Yes/no 
Duration of sick leave (weeks). 
Overall quality of life. 
Health status. 
Donor-perception of  the surgical scar. 
The donation’s impact on personal finances. 
Decision to donate again. 
Donor-perception of recipient health. 
x 
x 
x 
x 
 
x a 
x a 
 
 
 
 
 
xb 
xc  
 
x 
x 
x 
x 
x 
 
 
 
 
 
 
   
   
 
 
 
 
 
 
 
 
x 
x 
x 
x 
x 
x 
Confounding 
variables 
Unsuccessful recipient outcomes/life events.  
Protocol violations of pain regimen.  
Not-blinded study. 
Shift from pure laparoscopic approach to hand- 
assisted approach in the laparoscopic series. 
x 
x 
x 
x 
 
x 
x 
x 
x 
 
 
x 
x 
x 
x 
 
 
 
aPostoperative days 0+1 
bPostoperative days 0-2 
cPostoperative day 2 
 
 
 
Table 2. Independent variables, dependent variables and confounding variables in the quantitative 
studies (Paper I, II and III). 
 
Statistical analyses  
The SPSS statistical package version 12.0 (SPSS, Chicago Illinois) was used for all statistical 
analyses.  
 
Paper I 
The primary endpoints of this study were operative time, warm ischemia time, renal artery and vein 
length, complications from surgery, and analgesic administered and pain intensity at postoperative 
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days 0 + 1. We used descriptive statistics in the comparison of donor characteristics. Student’s t test 
was used to compare differences between groups with regard to surgical endpoints and analgesia - 
and pain data.  A 5 % level of significance was considered statistically significant. Analgesia - and 
pain data were analysed both based on intention-to-treat data (the one patient converted from 
laparoscopic to open surgery as well as the reoperated patients were classified in the laparoscopic 
group), and on censored data. Since there were no major complications or reoperations in the open 
group, statistical inferences have not been considered meaningful for the comparison between 
groups.  
 
Paper II 
Primary endpoints were: the amount of postoperative analgesic administered and self-reported 
postoperative pain at postoperative days 0-2 and at 1 month post donation, and duration of sick 
leave.  Power analysis revealed that 35 patients in each group would be required to detect 4-week 
post-operative pain differences found in previous studies (27), using a power of  80 % and a level of 
statistical significance of 5 %. Analysis was based on intention-to-treat. Accordingly, the one 
patient converted from laparoscopic to open surgery as well as the reoperated patients were 
classified in the laparoscopic group. Differences between the two treatment groups were analysed 
with χ2-statistics and Fisher’s exact test for categorical data. Continuous variables were analysed 
with Student’s t test. Regarding the comparison of duration of sick-leave between the groups, two 
patients in the open group suffering from chronic backache were excluded from the data analyses. 
We used multiple linear regression analysis to test the effects of surgical technique on duration of 
sick-leave, adjusting for donor-recipient relationship and patients’ socio-demographic 
characteristics.   
 
Paper III 
As in Paper II, the analyses were based on intention-to-treat. The main outcomes were overall 
quality of life and health status. A two-sided alpha of 0, 05 and 80 % power was used for tests of 
statistical significant differences between groups. A moderate effect expectancy for between-groups 
differences was set at 0, 6. Assuming a drop out of 10 % during the one-year follow-up, the 
necessary sample size to detect a 0, 6 effect expectancy would be 50 patients in each group. Ten 
point change on 0-100 scales for measures of health status was regarded as clinically significant. 
Differences between treatment groups were analysed using Fisher’s exact test for categorical data 
and Student’s t test for continuous data. Longitudinal analyses of overall quality of life and health 
status were performed using Repeated Measures Analysis of Variance, and paired t tests from 
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baseline to 1, 6 and 12 months after surgery. Change scores for the QOLS-N single sum score and 
the SF-36 subscales were calculated as the baseline score minus the postoperative score; a positive 
change indicating worsening and a negative change indicating improvement. Effect sizes were 
calculated as the standardized response mean (SRM), which is the mean change score divided by 
the standard deviation of the change score. A SRM of 0.2 - 0.5 was considered ‘small’, 0.5-0.8 
‘moderate’ and > 0.8 ‘large’ (115). We used a 5 % level of significance.  
 
Ethical considerations  
There may be ethical aspects involved in inviting living kidney donors to be randomized to either 
laparoscopic or open donor nephrectomy. However, the attitude of the Norwegian population 
regarding laparoscopic versus open surgery was quite balanced before and during study period. All 
donors were informed that there was no hard evidence in favour of either procedure. The 
questionnaires used were considered not to cause psychological distress for the participants. The 
study has followed the ethical guidelines of the Declaration of Helsinki (116) and was approved by 
the Regional Committee for Medical Research Ethics in South Norway.  The participants signed 
informed consent, were guaranteed anonymity and confidentiality, and the right to withdraw form 
the study at any time. 
 
Qualitative studies (Paper IV and V) 
As the purpose of Paper IV and V was to explore narrative donor experiences of going through 
open donor nephrectomy, qualitative research methodology was chosen for these sub-studies. 
Qualitative research is suited to gain understanding of people’s lived worlds, and how people assess 
the world around them (117). According to Malterud the notion “qualitative” refers to quality in the 
sense of features, character, nuances and complexity, or nature of the phenomenon under study 
(118).  Hence, qualitative methods might be applied on a descriptive level, and are more appropriate 
for understanding than for explanation. The aim of qualitative research is to investigate the meaning 
of social phenomena as experienced by the people themselves in their own context and, and in their 
natural setting (119).  
 
Design 
An explorative qualitative design with a phenomenological approach was chosen because this 
approach allows for the description of experiences as fully as possible as the persons in focus lived 
them. Thus, phenomenological research elicits the essence of concrete events and experiences that 
have a narrative form including descriptions of a person’s thoughts, feelings and actions (120). In 
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the present study the phenomenon of interest was the donors’ experiences of going through living 
donor nephrectomy the first year after surgery. Thus, the donors were prospectively followed for 
one year by in-depth interviews at one week and at one year after donor surgery. By doing so we 
were able to catch the immediate donor experiences of going through open donor nephrectomy (the 
short-term perspective), and to reflect donor experiences during the first year post donation (the 
long-term perspective).  
 
Participants    
Twelve Norwegian donors undergoing open donor nephrectomy during the period February – 
September 2003 at Rikshospitalet HF, and not participating in the ongoing randomized donor study, 
were recruited for the qualitative part of the study. Potential informants received information about 
the study, both orally and in writing, at the hospital. All donors asked gave their approval. The 
donors, who were consecutively selected to assure variety, were all above 18 years of age and were 
able to speak and understand Norwegian. The sample contained a broad variation in demographic 
characteristics such as age, gender, relationship to the recipient, settlement and occupation. The 
one-week and the one-year patient sample were identical.  
 
Data collection 
One-week interviews 
The one-week interviews were performed during February-September 2003, in a closed room with a 
relaxed atmosphere at Rikshospitalet HF while the donors still were in hospital, usually the day the 
donor departed. The interviews, which were audio-taped, were conducted using a semi-structured 
interview guide and lasted for approximately one hour. The interviews started with a briefing about 
the purpose of the study. Then the informants were asked to narrate their immediate experiences of 
going through donor nephrectomy. Examples of questions were: “How will you describe your 
immediate recovery from donor surgery?”, or “How will you describe being both a patient and a 
relative during the hospital stay?” A semi-structured interview guide, based on previous research on 
living kidney donation and clinical experience in the field, guaranteed that pre-determined issues 
were covered during the interviews (Figure 5). 
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One - week interview guide 
• Preparation: 
Experiences of the decision - making process.  
Experiences of preparing for donating. 
• Recovery from surgery: 
Experiences of being a fit individual and going through major operation. 
Experiences of the physical and mental recovery from surgery.  
Experiences of informational needs. 
• Donor – recipient relationship: 
Experiences of the donor – recipient relationship.  
Experiences of being both a patient and a relative. 
• Health assessment: 
         Experiences of having one kidney left. 
         Future outlook on own health. 
 
Figure 5. The one-week interview guide. 
 
Before ending the interviews the informants were asked if they had anything to add. After the 
interviews the donors had the opportunity to contact the researchers to discuss their experience of 
the interview situation.  
 
One-year interviews 
The follow-up interviews were carried out by telephone at one year post donation by two 
researchers during February – September 2004; one of the researchers also performed the 
interviews-series at the hospital one year before. A semi-structured interview guide was used, 
containing questions related to their experiences of own physical and psychosocial health, the 
donor-recipient relationship, transplantation outcomes of the recipient, and the medical follow-up of 
the donors (Figure 6). The interviews lasted for 30-50 minutes. In the body of the interview the the 
participants were asked to narrate their donor experiences using questions like: “How will you 
describe your physical condition the first year after the donation?” or “What is your experience of 
your medical follow-up during the first year after donation”? Also, probes were used to stimulate 
narration, such as: “What did you think then”? Before ending the interviews the informants were 
asked if they had anything to add. After the interviews all informants were invited to contact the 
researchers to add donor experiences, or to raise questions about the interview situation. 
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One - year interview guide 
• Physical donor  health 
Experiences of the physical condition the first year after donation. 
• Mental  donor health 
Experiences of the donors’ mental health the first year after donation.  
Experiences when transplantation fails. 
• Donor – recipient relationship: 
Experiences of the donor - recipient relationship the first year after 
donation. 
Experiences of the donor’s role during convalescence. 
• Medical follow up 
         Experiences of the medical follow-up from the health care system. 
 
Figure 6. The one-year interview guide. 
 
Analysis 
The recorded and transcribed data material from both interviews was analyzed in a 
phenomenological tradition. This process includes five steps described by Kvale (121).  Initially the 
text of the separate interviews was carefully read through to get a general impression of the data 
material. Then, the natural units of meaning as expressed by the living donors were determined by 
the researcher. Third, the theme that dominated a natural meaning unit was stated as simply as 
possible. The donor’s answer was read without prejudice and the statements were thematized. The 
fourth step consisted of interrogating the meaning units in terms of the specific purpose of the 
study: to answer how the living kidney donors experienced going through living donor 
nephrectomy. The themes of the meaning units were addressed with respect to such questions as, 
“What does this statement tell about living kidney donor – experiences?”  In the fifth step, the 
essential themes of the entire interview were tied together in a descriptive statement. The method 
thus involves a condensation of the expressed meanings into more and more essential meanings of 
the structure and style of being a living kidney donor. 
 
Ethical considerations  
The ethical guidelines of the Declaration of Helsinki (116) were followed in all part of the research 
process. Both the initial interview study and the follow-up study were approved by the Regional 
Committee for Medical Research Ethics in South Norway.  All participants were provided with oral 
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and written information about the aim of the study. The participants signed informed consent, were 
guaranteed anonymity and confidentiality, and the right to withdraw form the study at any time.  
 
RESULTS 
 
Paper I 
In this paper we summarized the results from the prospective, randomized study, with particular 
emphasis on donor safety, peri - and postoperative complications, and immediate postoperative pain 
at postoperative days 0 + 1, laparoscopic versus open donor nephrectomy. There were significant 
differences in favour of the open group on operative time, warm ischemia time, and artery - and 
vein length (p < 0. 01). Five major postoperative complications resulting in reoperations occurred in 
the laparoscopic group. These were caused by moderate bleeding from a port site (1), a forgotten 
sponge in the infraumbilical incision (1), jejunal perforation (2) and incarceration of bowel in a port 
site (1). There were no major complications in the open group. At postoperative days 0 + 1 the 
amount of ketobemidon administered were significantly in favour of the laparoscopic procedure (p 
< 0. 02). Also there was a significant difference in favour of laparoscopy on pain intensity in motion 
as measured by the VRS at postoperative days 0 + 1 (p < 0. 02).  
 
Paper II 
Paper II aimed to compare postoperative pain and convalescence, laparoscopic versus open donor 
nephrectomy, at postoperative days 0-2, and at 1 month after surgery. There was a significant 
difference in favour of the laparoscopic group regarding the amount of ketobemidon administered at 
day of surgery (p < 0. 01), but no differences between groups at postoperative day 1, and day 2. No 
difference was observed between groups on pain intensity at postoperative day 2, at rest or in 
motion. One month post donation significantly fewer donors in the laparoscopic group reported 
surgery related pain (p < 0. 02), or had used analgesics the last 24 hours (p < 0.05). The donors 
undergoing laparoscopic surgery reported significantly less pain intensity as compared to the donors 
in the open group at one month post donation (p < 0.002).  The duration of sick-leave was 
significantly shorter in the laparoscopic group (p < 0.01).  
 
Paper III 
In Paper III the aim was to compare overall quality of life and health status at 1, 6 and 12 months 
after surgery, and donor specific questions, laparoscopic versus open approach. While no significant 
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differences were found between groups in QOLS-N scores at any time points, we found a 
significant difference in favour of laparoscopic surgery regarding the SF-36 subscale bodily pain at 
one month postoperatively (p < 0.05). Analysis based on intention-to-treat revealed no long-term 
differences between groups in SF-36 scores. Both groups reached baseline scores in most subscales 
at 12 months. When subtracting the re-operated donors and the one converted donor of the 
laparoscopic group, significant differences in favour of  laparoscopy were revealed in the subscales 
bodily pain at 6 months (p < 0.05) and social functioning at 12 months (p < 0.05). QOLS-N scores 
at 12 months were significantly lower compared to baseline, but the changes did not exceed five 
points. No significant differences between groups were found concerning the donors’ perception of 
the surgical scar, the donation’s impact on personal finances, decision making, or the donors’ 
perception on recipient health. Concerning the latter, 91% of the donors in the laparoscopic group 
reported the recipient health to be about as expected or better, respective 87 % in the open group, 
with no significant difference between groups. 
 
Paper IV  
The aim of paper IV was to explore physical and psychosocial issues related to living kidney 
donors’ experiences of going through open donor nephrectomy at one week after surgery.  The 
results showed that all the participants had a positive attitude about the donation a week 
postoperatively. Their wish to donate was related to an altruistic perception of improving the life of 
another person. Thus, the participants considered the donation to be a very meaningful action. The 
donors’ main concerns related to the surgical experience were dealing with postoperative pain and 
nausea. Those suffering from nausea experienced that they were not adequately prepared to deal 
with this burden. Some participants also expressed that being a patient and a relative at the same 
time could be a stressful experience. When it came to the donor-recipient relationship, this was 
described as close and warm.  The donors had a positive outlook on own future health and expected 
to have regularly follow-up’s by the health care system after hospital discharge. 
  
Paper V  
In Paper V we explored donor experiences regarding physical and psychosocial health during the 
first year following donor nephrectomy. Though several participants experienced physical 
disincentives longer than expected post donation, all participants expressed an overall positive 
experience about being a donor a year after transplantation. Emotional distress, such as mild 
depression and feeling of loss, was reported. Donors experiencing unsuccessful recipient outcome 
suffered from severe physical and mental reactions. Yet, these donors reported that they were back 
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to normal condition a year later, remaining confident in themselves thinking they did what they 
could do to help a close family member. They did not regret donating a kidney. 
 
DISCUSSION       
 
There is a growing need for organs and many transplant centres have responded to this situation by 
expanding the living donor options. In Norway efforts are made to increase the donor pool and to 
continue the extensive use of living kidney donors. To date, there has been a lack of large, 
prospective follow up studies of the situation of living kidney donors. Thus, a major challenge 
facing this work was to expand the knowledge base in this area and the overall aim of the present 
work was to investigate clinical and patient-reported outcomes following living donor nephrectomy. 
A combination of quantitative and qualitative research approaches was applied to perform a broad 
evaluation. The quantitative approach was designed to assess the effect of laparoscopic versus open 
donor nephrectomy on clinical and patient-reported outcomes. In a randomized clinical trial of 122 
donors we prospectively collected data at baseline, in the immediate postoperative period, and at 1, 
6 and 12 months after surgery. The qualitative investigation was designed to prospectively explore 
experiences through in-depth interviews of 12 donors at one week and one year after surgery. In the 
following main results from the quantitative and the qualitative investigation will be discussed and 
put into the existing knowledge base within this area. Next, several methodological considerations 
and implications for clinical practice will be discussed. At the end of the section areas for future 
research are proposed.    
 
Main results (Paper I-III) 
 
Operative time, warm ischemia time, length of renal artery and vein, and peri - and postoperative 
complications 
Paper I mainly focused on donor safety, laparoscopic versus open approach. Not surprisingly, there 
were significant differences in favour of the open approach regarding operative time, warm 
ischemia time, and vessel lengths (Paper I). Thus, the results from our randomized study give 
support to previous reports (2, 27, 28), suggesting that the conventional open nephrectomy is 
superior to laparoscopy when it comes to operative time, warm ischemia time, and vessel lengths . 
However, while no major complications occurred in the open group, there was a high rate of major 
complications and reoperations in the laparoscopic series. Despite the fact that laparoscopic 
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nephrectomy obviously removes some important disincentives to live donation this technique may 
increase the risk of acute complications. In the present study two surgeons performed the 
laparoscopic nephrectomies and reoperations occurred in both the surgeons’ series. Yet, one may 
question if the experience of the laparoscopic surgeons has impacted on the results. The one with 
extensive experience performed 8 laparoscopic nephrectomies, resulting in one early reoperation on 
postoperative day 1. Of the 55 nephrectomies performed by the one with moderate laparoscopic 
experience there were 4 early reoperations between postoperative days 2-10, and 1 conversion to 
the open technique.  Although it is hard from our study data to draw any conclusion when it comes 
to experience and complication rate, it is likely that experience and training play an important role 
with regard to donor safety following laparoscopic surgery. In a recently published review article of 
open versus laparoscopic donor nephrectomy it is stated that many complications following 
laparoscopic surgery are attributed to the learning curve rather than true differences in the 
techniques (122). In another report, Vallancien et al claim that a minimum of 50 difficult operations 
are necessary to acquire adequate skill in laparoscopy, with a decrease in blood loss and operating 
time, provided such operations are performed sufficiently frequently. To train, the surgeon should 
perform at least 1 case a week during the first year of experience (123). Many researchers report 
comparable numbers of complication rates when comparing the two approaches (28, 30, 33, 34). 
This could be attributed to less complication rates in their laparoscopic series as compared with our 
series, or that there may be a tendency to underreport complication rates. The latter has also been 
debated by others (41). However, some researchers performing retrospective studies have similar to 
us, documented higher complication rates in their laparoscopic series (2, 45). Our randomized study 
gives support to these findings and thus brings important data into the existing knowledge base in 
this area, demonstrating that the laparoscopic technique should be introduced with great caution.  
 
Postoperative analgesics and pain intensity, duration of sick leave 
The main findings regarding pain data mainly were in favour of the laparoscopic group. Thus, when 
it comes to the administration of ketobemidon and pain intensity  measured by the VRS at 
postoperative days 0 + 1, the results from Paper I and II give support to previous research (8, 27-29, 
33, 105, 124-128), demonstrating considerable donor advantages of the laparoscopic approach in 
the immediate postoperative period. There were some minor violations of the analgesic protocol. 
Yet, when we subtracted the donors with minor violations of the analgesic protocol, and the 
reoperated and converted donors, the results remained unchanged. The pain data from this 
randomized study are important as laparoscopic donor nephrectomy was introduced to cause 
minimal harm to living kidney donors. It is likely to believe that the small skin incision resulting 
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from the minimal invasive technique causes less pain as compared to the larger incision used for the 
standard open technique. Our findings thus highlight an important benefit of laparoscopic surgery, 
as the ethics of live donation imply that the morbidity of the procedure should be as low as possible 
(129). Opposite to the VRS scores at postoperative days 0 + 1, we found no differences between 
groups on the VAS pain intensity scores at postoperative day 2 (Paper II). This was surprising, and 
one may reflect on possible explanations. First, it could be that that the postoperative pain 
management disguised actual differences between groups at postoperative day 2. Second, though 
the VAS in general has become a standard instrument for measuring pain intensity, it may be that 
the VRS could be a better instrument for use also at postoperative day 2 since the VRS already was 
an established instrument before study start, and is easy to use and to understand both for the staff 
and the patients (111, 112). Third, there is also a possibility that no difference actually existed 
between groups at postoperative day 2. Still, the latter may be difficult to understand since our 
findings at 1 month post donation revealed that donors following the laparoscopic approach 
reported significantly less surgical pain. Previous research supports our 1-month pain results (27, 
29, 33). Further, we found that the donors in the laparoscopic group had a significant shorter sick 
leave, compared to donors following open surgery. Since two informants in the open group reported 
that chronic backache, and not the donor surgery, was the reason for their prolonged sick leave 
period these were excluded from the data analyses of sick leave duration. In an additional analysis 
(intention-to-treat) we included the two informants in the open group suffering from chronic 
backache. Results showed an even greater difference between groups in favour of the laparoscopic 
surgery. Our findings regarding the VRS scores and duration of sick leave support Ruiz-Deya 
claiming that traits of recovery usually translate to time off work (130). Other studies from different 
countries, both randomized (27) and non-randomized (29, 33, 124) have documented shorter sick 
leave following the laparoscopic approach. Thus, our findings support previous research suggesting 
that laparoscopic donor surgery removes or diminishes important disincentives to live donation.  
 
Overall quality of life, health status and donor specific questions 
When it comes to overall quality of life we found no differences between groups at the QOLS-N 
scores at 1, 6 and 12 months. However, the health status investigation at 1 month demonstrated 
short-term benefits in favour of laparoscopy (Paper III), as the donors in the laparoscopic group 
reported significantly better SF-36 scores at the subscale bodily pain, also demonstrated in previous 
research (27-29). The 6 - and 12 months comparison of health status only revealed significant 
differences in favour of the laparoscopic group when we adjusted for re-operations and conversions 
(Paper III). When we subtracted the reoperated and converted donors in the laparoscopic group, we 
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found that the donors in the laparoscopic group reported significantly better at the subscale bodily 
pain (p = 0.032) at 6 months compared to the donors in the open group (n = 111). Also, we found a 
significant difference in social functioning at 12 months (p = 0.035) in favour of the laparoscopic 
group (n = 108). These findings may indicate that peri - and postoperative complications cause 
trouble for the patients for a long period after the donor surgery. This was also demonstrated at the 
follow-ups where the participants had the opportunity to write their own comments at the end of the 
questionnaires. Donors in the laparoscopic group experiencing peri - and postoperative 
complications commented on disincentives like pain and difficulties with performing their daily 
activities during the first year post donation. Nevertheless, while Perry’s retrospective study showed 
significant differences on the SF-36 domains bodily pain, physical functioning and role emotional 
in favour of laparoscopic surgery at 6 - 12 months post donation (29), our intention-to-treat analysis 
did not demonstrate any long-term group differences. Moreover, our findings do not support the 
single blind, randomized trial of Kok et al, revealing significant long-term differences between 
groups in favour of laparoscopy on most SF-36 domains (28). However, Kok et al also performed a 
prospective investigation of psychosocial and physical impairment after mini-incision open and 
laparoscopic donor nephrectomy (131). The findings from this study are in line with our findings, 
demonstrating no differences in SF-36 scores at 6 and 12 months follow up. Buell et al have 
reported similar outcomes, finding no significant long-term differences in the SF-36 scores between 
their laparoscopic and open series (32). Nevertheless, given our findings, it could be that a study 
design permitting more frequent follow-ups during the first 6 postoperative months would have 
been a better strategy for comparing laparoscopic and open donor nephrectomy. The results with 
regard to sick leave showed that the majority of the donors were back at work within 2-3 months. 
Hence, it is reasonable to believe that the ability to detect important differences between groups 
would be largest within this period. Furthermore, it may be that a disease specific instrument for 
living kidney donors would have detected long-term differences between groups. As generic 
instruments tend to cover a wide range of conditions, disease specific instruments are designed to 
focus on symptoms and disabilities related to a specific disease or treatment (15). However, there is 
a lack of disease specific instruments tested for psychometric properties for use in this patient 
group. When it comes to donor-recipient relationship it is a possibility that this may impact on the 
donors’ self reports on quality of life and health status. In the laparoscopic group, 19 % of the 
donors were not related to the recipient, respectively 22 % in the open group. We performed 
additional analyses of the unrelated donors’ scores on health status and overall quality of life during 
follow-ups. Results showed a significant difference in favour of the laparoscopic group on the 
subscale bodily pain at 1 month post donation (p = 0,037). There were no significant differences 
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between groups with regard to other SF-36 scores, and QOLS-N at 1, 6 and 12 months. This 
indicates that in the present study the relationship to the recipient probably has played a minor role 
concerning donor reports on quality of life and health status. 
 
Looking at the total sample, our follow-up results revealed that living donor surgery clearly 
impacted the donors’ quality of life and health during the first month after surgery. In particular, the 
donors reported low 1 month-scores at the subscales role physical, bodily pain and vitality. The 
findings from our randomized series are important because previous reports from retrospective 
studies have concluded that the donors’ quality of life was minimally affected by donor 
nephrectomy (42, 132). However, these studies were limited by the wide span of time since 
donation took place, and a retrospective design, and like that illustrate that different research 
designs may provide quite opposite study results. This may indicate that frequent, prospective 
follow-ups after surgery are necessary to provide reliable information of the consequences of going 
through donor nephrectomy. At 12 months our data demonstrated that most donors in both groups 
had returned to preoperative levels in most SF-36 subscales and were comparable to those in the 
general Norwegian population (104). Concerning the donors’ attitude to the surgical scar one may 
reflect on why the donor scores were comparable in the two groups. Initially, we expected that the 
donors in the laparoscopic group would express a more positive attitude to the scar compared to 
donors in the open group as a consequence of the small laparoscopic incision. However, the 
altruistic character of donation raises the possibility of a situation in which the donors feels the 
health of the recipient is superior to that of him - or herself (133). This may explain why there were 
no differences between groups regarding attitude to the surgical scar. Our results are in line with 
previous studies (29, 134).   
 
Main results (Paper IV-V) 
In the qualitative studies (Paper IV and V), we explored donor experiences at one week and at one 
year after open donor nephrectomy. Though giving support to data derived from the randomized 
trial, the qualitative data above all provided knowledge of the lived experiences of going through 
donor surgery as narrated by the donors themselves. In the following results from Paper IV and V 
are discussed. 
 
Overall attitude towards donation 
One main finding in Paper IV and V was that the donors had an overall positive experience about 
being a donor. Although the donors reported on some negative experiences during the year after the 
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donation, the in-depth interviews explored that the donors’ overall satisfaction and positive attitude 
towards the donation remained stable a year after surgery. Data from our research support previous 
reports (48, 58, 63, 65, 135, 136). The positive donor attitude may reflect several conditions related 
to live donation. The fact that the donors had been able to help a close family member may be 
thought of as very meaningful for most donors and may have ruled out possible negative feelings. 
Some donors also related the donation to own human existence, including increased self esteem, a 
resetting of values, and personal growth. Similar findings have been reported earlier (58). Other 
donors mentioned that the aspect of self-benefit was part of their positive donor experience: after 
the transplantation both the recipient’s and the donor’s life had become easier, or more active. 
These phenomena may contribute to explain why positive donor attitudes emerged as the dominant 
theme in both interview series. Reports from other studies support this assumption (61, 63, 65). Our 
findings put forward the importance of encouraging the donors to focus on positive donor 
consequences as this may strengthen the donors’ coping strategies. However, as previously 
described in donor literature (58, 63), high rates of donor satisfaction may be biased by the donors’ 
wish to present themselves in a socially desirable light, and to justify the pain and expense of 
having donated an organ. This phenomenon may have influenced on some of the donors’ 
descriptions. 
 
Donor-recipient relationship 
The one-week and one-year data suggest that the donors expressed a continued sense of closeness 
with their recipients during the first year post donation. Concern and love were expressed 
repeatedly during both interview series. It was somewhat surprising that the donor-recipient 
relationship remained strong also a year after the donation. One might suppose that the donor 
experiences revealed in the present investigation, like disincentives from surgery, conflicting donor 
roles in the postoperative period, or unmet expectations regarding medical follow-up, would impact 
negatively on the relationship. Yet, previous research has demonstrated, in line with our findings, 
that the donor-recipient relationship in most cases remains stable, or more close, in the time after 
donation (48, 55, 63). An explanation may be that the donating process creates very strong bonds 
between the donor and the recipient. Also, significant persons in the donor’s and the recipient’s 
network including family, friends and health professionals probably act in a way that strengthen 
these bonds. Further, the result may also reflect a careful donor selection, and that the donors had 
been given enough time to reflect on their decision to donate pre donation. Finally, the donors who 
participated in the in-depth interviews were all close relatives to the recipient and this may be 
reflected in the strong donor-recipient relationship post donation. However, from a scientific view 
 42 
one must not forget that our sample was small. It could be that a larger sample would explore more 
variations in the data, including descriptions of negative donor-recipient relationships. To sum up, 
our investigation suggests a strong and stable donor-recipient relationship during the first year post 
donation. Still, as the sample only consisted of 12 participants the results must be treated with 
caution.    
 
Donor health post donation 
Though a major finding was that the donors were back in normal health condition a year after 
surgery, several donors expressed that they experienced problems related to donor surgery longer 
than expected. The donors’ health problems were related to emotional distress, physical disincentive 
and unsuccessful recipient outcome. Our qualitative data confirm previous research (45-49, 59, 66, 
137).  Transplant professionals must not underestimate the donors’ transition from health to illness. 
According to Fehrman-Ekholm it is a dilemma resulting from the fact that the donors generally 
consider themselves to be healthy (50). Before the donation the donors are informed that donor 
nephrectomy is associated with very low morbidity and mortality.  Moreover, a report concerning 
life insurance for kidney donors demonstrated that 36 of 38 insurance companies in the USA did not 
consider kidney donation to increase risks for medical problems in the donors (138). Opposite, 
several studies have documented adverse outcomes following living donor nephrectomy (7, 139-
141). In order to bridge the gap between donor expectations and the risk of negative donor 
outcomes, and as the selection criteria for donors has become less restrictive, realistic information 
and education should repeatedly be offered to the potential donor. During the one-year interviews 
the donors expressed clear expectations of regular medical follow-up after hospital discharge. 
However, several informants experienced that these expectations were not always met. In a Swedish 
study of 451 donors it was reported that 51 % of the donors were not regularly examined after the 
donation (51). This study gives support to the present work and suggests the need for a common, 
mandatory donor follow-up by nephrologists after donor discharge from hospital. 
 
Donor reactions when transplantation fails 
One main finding revealed in paper V was the reactions of the 2 donors experiencing bad 
transplantation outcome. Their response pattern indicates that unsuccessful transplantation outcome 
may evoke severe reactions, and thus demonstrates the vulnerability of being a living kidney donor. 
Knowing that there was a strong bond between the donors and their recipients, and knowing that 
donors in general show great concern about the recipients, it is not hard to understand the donors’ 
reactions. Though this result is limited by the small donor number, the seriousness of such events 
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can not be underestimated. As well, previous reports support our findings, suggesting that adverse 
recipient outcomes may result in negative feelings and grief by the donors (59, 66, 67). Potential 
donors need to be informed of all outcomes they may potentially face and harms may be minimized 
through careful donor selection. Also, health policies which fairly reimburse the donors for their 
non-medical expenses may help reduce undue stress.  Our data revealed that there was a gap 
between the donors’ needs of support and the help given from health professionals. Donor support 
and medical follow-up from health care team is essential. Recent studies have shown that the donor 
themselves requested such follow-up (57, 142, 143). For those facing adverse outcomes, early 
counselling may help alleviate psychosocial morbidity.  
 
Methodological considerations    
In the following methodological considerations related to the quantitative and the qualitative studies 
are discussed. In the end of the section the combination of the two different approaches will be 
commented on. 
 
Quantitative studies 
We used a randomized, controlled design. Random assignment creates two or more groups of units 
that are probabilistically similar to each other on the average. Ideally, any outcome differences that 
are observed between groups are likely to be due to treatment (144). Thus, the randomized trial is 
often referred to as the gold standard. Yet, many challenges occur when performing a randomized 
controlled trial in a clinical setting. In the following some important threats to reliability, validity 
and generalization in the present work are discussed. 
 
Reliability 
Reliability, or internal consistency, is concerned with error in measurement (107). According to 
Fayers, patients whose quality of life status has not changed should make very similar, or 
repeatable, responses each time they are assessed. If there is considerable random variability, the 
measurements are unreliable (15). Thus, assessment of reliability consists of determining that a 
scale or measurement yields reproducible and consistent results. Cronbach’s alpha is the method 
used most widely for this purpose (145). When it comes to the reliability of postoperative pain 
measurements it is well-known that pain assessment is challenging. We performed pain assessments 
in a busy clinical setting in patients recovering from major surgery. In the present study some 
patients may have been uncomfortable with participating in bed-side interviews in the immediate 
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postoperative period while suffering from side effects of surgery. Also, we used two different 
instruments for assessing postoperative pain intensity in the recovery period (The VRS and the 
VAS) and it is possible that this caused confusion in the participants. This may have reduced 
reliability. Yet, to increase reliability of the pain assessments the donors were provided with oral 
and written information about the procedure in advance. Only few, trained researchers and expert 
nurses performed the standardized data collection procedure. Further, the bed-side interviews were 
scheduled at a quiet period of the day to secure a relaxed atmosphere during the pain assessment. 
Finally, the pain instrument used had previous been tested and had shown satisfying properties with 
regard to reliability (108, 109).  Concerning overall quality of life and health status we judged 
reliability of the instruments used to be satisfying as Cronbach’s alpha of of the QOLS-N ranged 
from 0.89 to 0.90, and of the SF-36 from 0.67 to 0.94, indicating intern consistency and stability of 
both instruments. Similar results have been found in other studies (85, 91).  
 
Internal validity 
Internal validity of a study refers to the extent to which it is possible to make an inference that the 
independent variable is truly influencing the dependent variable and that the relationship is not 
spurious (97, 146). A high degree on internal validity enables the researcher to rule out rival or 
alternative explanations to causal interpretation. To check the internal validity one can ask: “Was 
the effect observed on the dependent variable actually due to the action of the independent 
variable?” Though the design used in this study possesses a high degree of control because of the 
manipulation and the randomization and though we used valid instruments to measure patient 
reported outcomes, there were some important factors distorting the outcome variables of the study. 
The most important confounding variables threatening internal and external validity in the present 
study are illustrated in Table 2 and will be discussed in the following. 
 
A limitation of our study design was that we did not directly integrate recipient data in our follow-
up analysis. Previous research has shown that unsuccessful transplantation outcome influences the 
donors’ health and quality of life (31, 49, 66). Some donors in the study sample experienced 
unsuccessful transplantation outcome during study period. This may be a threat to internal validity 
because unsuccessful transplantation outcome may have affected the donor scores at the 
questionnaires at 1, 6 and 12 months follow up. When we designed the study several reasons for not 
integrating recipient data were discussed. The donors were randomly allocated to laparoscopic or 
open surgery and it was likely to believe that randomization would distribute confounders equally 
between the two groups related to recipient outcome. Further, quantitative and qualitative follow-up 
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data on the donors were collected several times during the first year after donation and we 
considered it too demanding to collect recipient data paralleled to donor data. Finally, our design 
allowed for adjustment of changes in life events during the study period. The donors were asked to 
report on the occurrence of serious life events, such as illness and death of a close family member 
or friend, in the periods between the follow ups. The results showed that there were no significant 
differences between groups in donors reporting serious illness or death of a close family member or 
friend. Moreover, at 12 months the donors were asked to report on their perception of the recipient’s 
health. Results showed no significant difference between the groups.  As well, it is documented that 
adverse recipient outcomes most often occur more than a year after the transplantation (147-149). 
To sum up we believe that we, to a certain extent, were able to capture and control for a possible 
confounding variable of this study related to donor reactions in case of adverse recipient outcomes. 
Nevertheless, even if we believe that we to a certain extent were able to control for a possible 
confounding variable related to adverse recipient outcomes, we recommend integration of recipient 
data for future donor studies measuring patient-reported outcomes. Such data are informative and 
provide accurate information to allow for the adjustment for recipient outcomes on donor-data. 
 
There were minor violations of the analgesic protocol. Examples of violations were discontinuation 
of ketorolac in two patients due to side effects, and intravenous doses of proparacetamol replaced 
by oral paracetamol. Protocol violations may have affected the results of the donors’ pain ratings, 
and thereby reduced the internal validity of the study. To evaluate the effect of this error we 
subtracted the donors not following the analgesic protocol from the pain analyses. The findings with 
regard to postoperative pain remained unchanged. We therefore believe that violations of the 
analgesic protocol had only limited impact of the pain results.  
 
A possible “Hawthorne effect” (77, 97) may have impacted the donors, and in particular the donors 
in the laparoscopic group. The present study was not blinded and the donors in the laparoscopic 
group knew that they were randomized to go through minimal invasive surgery. Also the donors’ 
family, as well as the staff, were informed about the result of randomization. This could be a threat 
to internal validity in the way that these donors, their family, and the staff possibly expected the 
donors in the laparoscopic group to have a more rapid and easy recovery as compared with the open 
group, and thereby behaved in a particular manner. There may be a chance that this affected the 
responses of the donors in the laparoscopic group. It was difficult to rule out this effect in the 
present study since it in general is hard to fully obscure which surgical method have been used. 
Besides, blinding is only possible in the immediate postoperative period before the wound dressings 
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are removed, being of less importance in long-term assessments. However, the attitude of the 
Norwegian population regarding laparoscopic versus open surgery was balanced during the study 
period and the donors were informed that there was no hard evidence in favour of either procedure. 
 
External validity 
External validity refers to the generalizability of the research findings to other samples (77, 97). The 
central question when assessing the generalizability of a study is: are the findings relevant beyond 
the experimental condition? Both the representativeness of the participants and the experimental 
settings must be considered when judging whether the findings can be applied elsewhere (150). To 
assure that the sample of the study should be representative for Norwegian donors we made study 
participation as convenient and un-extraordinary as possible. Donors fulfilling the inclusion criteria 
were considered eligible for the study. Exclusion criteria were history of extensive upper abdominal 
surgery, findings suggesting right nephrectomy, and not understand and speaking Norwegian. There 
was no further selection. Information to potential donors across the country was spread by 
nephrologists at local hospitals. Also, all donors were informed about the study after admission to 
Rikshospitalet HF. As there is only one transplantation centre in Norway, and as there is a regular 
exchange of information between the local nephrologists and the transplant professionals at 
Rikshospitalet HF, we believe that almost all potential donors who fulfilled the inclusion criteria 
were informed about the study and were invited to participate. The main reasons for 118 donors not 
participating in the study during the study period were administrative circumstances (the 
laparoscopic surgeons were not available), right side chosen, and the donors had a history of 
extensive previous abdominal surgery. During follow-ups there were five drops out in the 
laparoscopic group versus 3 in the open group. Those donors being reoperated or converted to open 
surgery were not among the drop outs. We performed additional analyses of non responders to test 
baseline characteristics and scores of the main instruments. No statistically significant differences 
were found in donor characteristics, or in baseline scores of the main instruments between 
responders and the non responders. Additional to test for baseline scores, we tested the non 
responders’ scores at one month follow-up. The results showed that scores of non responders’ in the 
open group were comparable to the total sample. In the laparoscopic group three out of five non 
responders were comparable to the total sample, whereas two non responders had low scores at 
most of the SF-36 areas. Thus, it is possible that the two non responders in the laparoscopic group 
would have influenced negatively at the 6 - and 12 months assessments if they had responded to the 
long-term assessments. On the topic of sick leave one of the two non-responders was included in 
our analysis, reporting a sick leave period of 10 weeks. The other was unemployed (a housewife) 
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and thereby not part of the assessment. However, both non responders reported gave comments at 
the end of the 1- month questionnaire. One reported serious worries because of the course of the 
recipient (her husband). The other reported that she had suffered from chronic headache for many 
years. This may reflect that their low SF-36 scores were caused by problems not directly related to 
laparoscopic surgery.  
 
The research situation is also essential when judging the generalizability of a study (97). The 
question is whether or not results obtained in one setting can be generalized to another setting. In 
the present study a particular anaesthesia and postoperative pain management was established to 
ensure that all donors received a common regimen guided by the same standardised protocol. After 
the study was ended this anaesthesia and postoperative pain management has been established as a 
standard regime for patients going through laparoscopic nephrectomy. However, when it comes to 
open surgery, the standard regime for these patients is epidural analgesia. According to Brink and 
Wood (150), if the effect obtained is applicable only to the specific setting of the study, the 
relevance of the findings beyond the experimental condition can be reduced. Since the study regime 
is not established as a standardized treatment for all living kidney donors, this may be a threat to the 
generalization of our pain results. Another threat to extern validity in the present work is the switch 
from a pure laparoscopic technique to a hand assisted laparoscopy during the study period. Today 
the hand assisted, and not the pure laparoscopic technique, is the established treatment with regard 
to laparoscopic donor nephrectomy. This may threaten external validity of the work. However, 
taking into account that the infra-umbilical incision and extent of dissection were comparable with 
both techniques, we believe that the impact on the donors’ assessments were much the same. Earlier 
reports concerning laparoscopic surgery support this supposition (26, 151).  Finally, the high 
complication rate in our laparoscopic series is a serious threat to extern validity. One may suppose 
that when no learning curve longer exists for the laparoscopic procedure at our centre, the 
complication rates are reduced. Previous reports support the assumption that a relationship exists 
between the surgeon’s experience and the complication rate in the area of laparoscopic surgery 
(152-153). Thus, the occurrence of a high complication rate in the present study may not be 
representative for the future situation of laparoscopic donor nephrectomy at our centre, and thereby 
the external validity of the present study may be reduced. The high laparoscopic complication rate 
raises an important question: in the comparison of new and established surgical methods, at what 
time should randomized studies be performed? It is clear that the complication rate with regard to 
new surgical methods is reduced in centres with a high volume. The present randomized study was 
started three years after the introduction of laparoscopic donor nephrectomy at Rikshospitalet HF. 
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We were then still in the learning phase of the method and it is possible that the number of 
complications could have been lower at a later stage.  
 
To sum up, although we used a prospective, randomized design, there are several threats to 
reliability, internal validity and external validity in the present study that may affect the findings. 
Consequently, caution should be used when drawing conclusions concerning the results of the 
quantitative part of the study.   
 
Qualitative studies 
Reliability and validity 
As the concepts of accuracy and truth are relevant in all scientific work, the question of reliability and 
validity must also be raised within qualitative studies. Sandelowski and Barosso (154) and Kvale (121) 
discuss the components of rigor in qualitative studies and propose several strategies to enhance 
reliability and validity in qualitative research. These are literature searches ahead of the study, the use 
of brief and simple interview questions, avoiding leading questions, use of expert peer debriefing, and 
techniques for establishing consensus in the research team. In our qualitative approach we used several 
strategies to help ensure scientific quality of the study. The research questions and the interview guides 
were based on literature reviews and the researchers’ experiences in the field. Still, in interview studies 
the researcher is himself (or herself) the research instrument (121), and to be a good interviewer one 
must be able to assist the informants in the unfolding of their narratives. This is important because it is 
during the interview phase that knowledge is constructed through the interaction of the researcher and 
the participant (121). Although the researchers in the present study had broad knowledge of the 
interview theme and previously had performed in-depth interviews, it was challenging to pose clear 
and short questions to the informants during the first interviews series. Another challenge was to allow 
the informants to finish what they were saying and to let them proceed at their own rate of thinking 
and speaking, and to tolerate pauses during the interviews. Also, avoiding leading questions and 
remembering to question critically to test the reliability and the validity of what was said, was easier 
said than done. To assure data quality, two researchers performed the interviews, one of them 
interviewing and the other adding supplementary questions when necessary. Though we attempted to 
standardize the interview situation it is possible that nonverbal cues from both researchers and 
respondents affected the respondent’s answers. Also, the fact that the interviewers were affiliated to 
the transplant unit may have influenced the participants’ descriptions. Follow-up interviews at one year 
were conducted by telephone because the donors were spread around the country. One may argue that 
in-depth interviews should be performed face-to-face. However, contact between the donors and the 
 49 
researcher was already established during the one-week interviews, performed face-to face before the 
donors’ discharge from hospital. During the data analysis phase we had regular meetings with clinical 
experts to get peer opinions and to assure an accurate reflection of the interview data. The experts 
represented transplantation professionals concerning the pre donation phase, donor surgery, and post 
donation follow-ups. A well-established method for data analysis was chosen (121) and we used 
multiple interpreters to ensure trustworthiness during this process.  Alternative ways of interpreting, 
categorizing and organizing data were discussed carefully until consensus was established in the 
research team.   
 
Transferability 
The main objective of the qualitative studies was to provide rich descriptions of the unique situation 
of 12 donors going through living kidney donation, as narrated by the donors’ themselves. A central 
question is: can the results be transferred to other living kidney donors? From a strictly scientific 
view the findings can not be generalized to other living kidney donors because they are based on a 
qualitative research methodology and a small sample size. Though the participants were 
consecutively selected for interviews, the sample contained a broad variation in demographic 
characteristics. However, the sample comprised 12 participants and it is likely to believe that a 
larger sample would have increased the variety of the findings. Yet, since large sample sizes 
represent much work in organizing and interpreting the data, and since we had a repeated research 
design (totally 24 in-depth interviews were performed in the period 2003-2004), we judged it to be 
too time consuming to have a larger sample. Nevertheless, Kvale warns against large quantities of 
data in interview studies because it can be hard to handle them in a meaningful way. In stead, the 
focus should be on the content, the depth, and the qualitative meaning of what is said (121). 
According to Malterud, the findings from a qualitative study are not thought of as facts that are 
applicable to the population at large. Rather they are descriptions, notions, or theories applicable 
within a specified setting (155). Thus, the results from our qualitative studies provide relevant, new 
knowledge and a deeper insight into the situation of 12 Norwegian donors, relevant both for 
potential donors and transplant professionals. Like that, the results may be transferable to clinical 
settings in which transplant professionals counsel living kidney donors in the different stages of the 
donation process.   
 
Combining quantitative and qualitative methods 
We performed a combination of methodological approaches to study the outcomes of living donor 
nephrectomy broadly and in depth. The main argument for a combined approach was that a mixed 
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model would enable us to profile the complexity of going through donor surgery, since diverse 
research methods may shed light on different aspects of a phenomenon. In addition to quantifying 
self-reported outcomes following donor nephrectomy the qualitative investigations allowed us to 
extract the meaningful content of the donor experiences narrated by the donors through personal 
interviews. The use of quantitative methods was appropriate in the comparison of two surgical 
methods of donor nephrectomy as the randomized, controlled trial provided us with specific 
information about the effect of surgery.  Data from the qualitative studies gave in-depth descriptions 
of the reality of going through open nephrectomy as narrated by the donors themselves. Thus, in 
this thesis the two approaches can be thought of as complementary, providing transplant 
professionals with broad clinical knowledge based on different perspectives of the donors’ situation. 
Another advantage of mixed models lies in the potential for enhancing validity of study findings. 
The quantitative and the qualitative studies in this thesis showed similar trends concerning donor 
health the first year after surgery. When researchers’ hypotheses are supported by complementary 
types of data, they can be more confident about the validity of the results (97, 156).  
 
However, the use of multiple research designs may also be challenging as the data derived from one 
design may demonstrate weaknesses of the opposite design. In the present study the qualitative data 
revealed severe donor reactions when transplantation failed. This finding demonstrated the 
importance of integrating recipient data in donor studies, and thus revealed a weakness in our 
quantitative investigation concerning the lack of recipient follow-up. On the opposite, one may 
argue that if we had performed the qualitative interviews before designing the quantitative study we 
probably would have integrated recipient data in our quantitative 1, 6 and 12 months follow-up. 
This demonstrates how mixed model also may strengthen the design of a study. Further, one could 
claim that the triangulation between quantitative and qualitative approaches generates confusion 
about the epistemological and ontological bases that underlie each distinct approach. Qualitative 
research is often seen to represent a distinctive paradigm compared to quantitative research (157, 
158), drawing on text instead of numbers, applying procedures for interpretation of meaning instead 
of statistics to calculate probabilities, aiming for wholeness rather than details, and acknowledging 
the involvement of the researcher in the construction of knowledge (118). Yet, in the present study 
we experienced the similarities of the approaches to be more apparent than the differences as both 
approaches are based on solid epistemological traditions, aiming to aggregate new knowledge 
within a field by a systematic collection, organization and interpretation of data.     
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Implications for clinical practice 
This thesis adds multidimensional assessments to the existing knowledge base in the area of living 
kidney donation, with particular emphasis of patient-reported outcomes. According to Osoba (159) 
patient-reported outcomes in clinical practice has been shown to lead to a better understanding of 
patients’ concern with improvement in counselling and referral for required services. Potentially, 
such assessment should also be used to monitor the progress of a patient’s disease and benefit from 
treatment. Data derived from this study affirm that attention should be further paid to several 
aspects of living kidney donation. Following strategies for clinical practice are proposed:  
 
In several transplant centres the open technique is today the only established procedure regarding 
living donor nephrectomy. In the introduction of laparoscopic donor surgery it should be kept in 
mind that this method is still evolving. Essential factors for a successful laparoscopic approach are 
long-lasting experience within the field and technical expertise needed to perform the operation.  
 
Concern has been raised about whether living donors are always completely informed about the 
risks that are involved regarding donor surgery. Clinical and patient-reported outcomes derived 
from our study, and others (160, 161), highlight the importance of correct and neutral preoperative 
information from health professionals to potential donors. Our findings revealed that the donors’ 
decision process mainly was based on emotions and altruistic feelings. Further, a high complication 
rate was revealed in our laparoscopic series. Balanced information about the risks and benefits 
inherent in the donation process may be one way of promoting appropriate coping strategies for the 
donors. Also, it is important that the donors have sufficient time to reflect on the decision to donate.  
 
The unique situation of caring for both the recipient and the donor while at hospital provides 
additional challenges for the transplant staff. It is clear from our study that the donors experienced 
concerns and worries regarding the recipient, resulting in less focus on own needs during recovery. 
Thus, it is vital for transplantation professionals not to underestimate the donors’ needs, as well as 
donor transition from health to illness, and to organize donor programmes with as much focus on 
the donor as on the recipient. Some transplantation centres provide accommodation in a two-bedded 
side ward for the donor and the recipient. At our centre it has been a tradition to care for the donor 
and recipient in separate rooms within the same ward, so that if any clinical problems emerge they 
can be managed without emotional stress to the other part. Data from the in-depth interview series 
support the continuation of this tradition. According to our study results, the continuity of care after 
hospital discharge was missing for some of the donors, despite the health professionals’ assurance 
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of medical follow-up after donation. This finding is supported by previous research (51, 66,162) 
and demonstrates the need of a mandatory medical follow-up on a regular basis for all donors, in 
accordance with the recommendations of the Amsterdam Forum on the care of the living kidney 
donor (163). In case of graft failure, or death of the recipient, an active approach is required by 
transplant professionals to give thoroughly support to the donors.    
 
Future research   
This thesis of clinical and patient-reported outcomes has illuminated complex factors into the core 
of living donor surgery. In light of clinical and methodological challenges raised by this study 
future research questions in this area are proposed.    
 
Post surgery donor outcomes need to be studied further, both in a clinical and patient-reported 
perspective, and at a time when the laparoscopic surgeons have gained experience with the 
laparoscopic technique to rule out biases of the studies caused by learning curve, and thereby test 
the generalizability of our findings. Frequent follow-ups during the first postoperative months are 
necessary to assure that effects from surgery, and any anticipated changes, will be captured. 
 
As most post donation follow-ups have been retrospective, it is essential that future studies have a 
prospective design. Such studies will benefit from a long-standing study approach, which implies 
finding out more about longitudinal consequences of living donor nephrectomy. Also, data on 
recipients’ course should be collected paralleled, such as survival and acute rejection rates, to allow 
for the adjustment for recipient outcomes on donor-data. 
 
There is a lack of translated, disease specific instruments tested for psychometric properties for use 
in living kidney donors. Hence, developing such instruments is essential to provide researchers and 
clinicians with useful and rich patient information, in addition to compare donor data across of 
countries.    
 
The findings from our qualitative investigation indicated that being a donor may be a complex 
experience. More research is needed to fully understand the complex donor situations and donor 
reactions, and in particular when it comes to donor complication related to donor nephrectomy and 
adverse recipient outcome. Further series of repeated in-depth interviews are needed to fully 
understand donor needs. It is essential to have large enough samples to capture a variety in donor 
experiences. 
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At the very last, our study revealed that medical follow-up of living kidney donors varied within 
local health districts. Hence, there is a need to evaluate existing follow-up routines, both by data 
derived from health professionals and from donors. Standardized programmes should be established 
to ensure regular donor contact with local nephrologists post donation. An evaluation study of 
medical follow-up routines may be the first step in establishing a mandatory programme throughout 
the country.  
 
CONCLUSIONS 
1. The quantitative and the qualitative investigation of patient-reported outcomes following donor 
nephrectomy show that both laparoscopic and open living donor nephrectomy clearly impact 
the donors’ overall quality of life and health status. However, a year after surgery the majority 
of the donors was back in normal condition and remained satisfied with their decision to 
donate.   
 
2. The randomized trial demonstrates that conventional open donor nephrectomy is superior to 
laparoscopic donor nephrectomy with regard to donor safety. The high rate of complications 
in the laparoscopic series indicates that the laparoscopic technique should be introduced 
with great caution. 
 
3. The short-term data support the view that an uncomplicated laparoscopic donor 
nephrectomy has important advantages such as less postoperative pain, better health status 
and a shorter sick leave period as compared with the open approach. The 6 - and 12 months 
data only revealed significant differences in favour of laparoscopy when adjusting for re-
operations and conversions. We therefore conclude that long-term benefits are hard to prove 
in favour of laparoscopic surgery.  
 
4. In-depth interviews revealed that a positive feeling about being a donor was the dominant 
theme in the donors’ experiences at one week and at one year after the donation. Though 
experiencing disincentives from surgery during the first postoperative period, the donors 
expressed that they were back to normal condition a year after surgery, also confirmed by 
the quantitative investigation.  
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5. Donor reactions when transplantation failed were characterized by severe physical and 
mental reactions. Yet, the donors did not regret donation, but remained confident in 
themselves, thinking they did what they could do to help a close family member.  
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ERRATA 
Formal errors which have been corrected in the thesis:    
 
Page 16:  … at postoperative days 0, 1 and 2; and (2) postoperative pain intensity as measured by a visual 
analogue scale (VAS) at postoperative day 2 (Paper II). 
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Papers, errata 
Paper I Page 1238, Table 2. Explanation text below Table 2, regarding analgesic requirements: “Values 
in brackets are intention-to-treat data… ”, should be replaced with “Values in brackets are 
cencored data…” 
Page 1439, Surgical techniques. Starting on line 6, the correct numbers are: “The first  
17 laparoscopic donor nephrectomies…The last 46 laparoscopic...” 
Paper II 
Page 1440, Table 2. The correct amount of analgesic requirement is: 
                                          Laparoscopy      Open Surgery              N             p-value 
Day of surgery                     13.1 (9.2)               17.8 (10.7)          63/59            0.010 
First postoperative day        15.0 (13.4)              18.6 (15.4)         63/59             0.157 
Page 65, Surgical techniques. Starting on line 3, the correct numbers are: “The first  
17 laparoscopic donor nephrectomies …The last 46 laparoscopic…” 
Page 66, Health status. Last paragraph, the correct text is: “SRM for changes from  
baseline to 12 months varied between 0 and .55, however, most effect sizes were less  
than .30, indicating no or irrelevant changes. 
Paper 
III 
Page 67, Figure 1. 95 % CI should be replaced by Mean scores subscale SF-36. 
 
